Advertisements


Prana to start Phase 1 clinical trial study of PBT434

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Alnylam Files Clinical Trial Application for ALN-AAT02 in UK

Alnylam Pharmaceuticals (ALNY) submits a Clinical Trial Authorization application in the U.K. to start a phase I/II study on its early stage candidate, ALN-AAT02, for treating alpha-1 liver disease. Alnylam Pharma.....»»

Category: dealsSource: nytOct 4th, 2018

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Clovis Oncology shares dropped on Friday after the company announced initial data from its Phase 2 clinical trial of Rubraca at the ESMO 2018 Congress......»»

Category: blogSource: 247wallstOct 19th, 2018

Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis. Catalyst Pharmaceuticals, Inc. CPRX, enroled.....»»

Category: worldSource: nytApr 20th, 2018

Biohaven allowed to proceed with BHV-3241 Phase 3 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 19 min. ago

Veru initiates Phase 1b/2 clinical trial for VERU-1111

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Incyte treats first patient in Phase 3 clinical trial of itacitinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data

Shares of Ultragenyx Pharmaceutical Inc. rose 2.9% in premarket trade Tuesday after the company announced positive results from a safety and efficacy study looking at a treatment for patients with lo.....»»

Category: topSource: marketwatchJan 22nd, 2019

Avedro IPO: Speculative, But With An Ongoing Phase 3 Clinical Trial

Avedro IPO: Speculative, But With An Ongoing Phase 3 Clinical Trial.....»»

Category: topSource: seekingalphaJan 22nd, 2019

Lilly Stops Lartruvo Promotion as Confirmatory Study Fails

Eli Lilly's (LLY) Lartruvo combo is unable to demonstrate the clinical benefit for the primary endpoint of OS rate in a phase III study re.....»»

Category: worldSource: nytJan 21st, 2019

Synlogic announces publication of clinical data from Phase 1 study of SYNB1020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

Mirati Therapeutics doses first patient in Phase 1/2 MRTX849 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 15th, 2019

FDA pilot program could help Wave avoid orphan-drug pitfalls

Wave will work with FDA officials during the pilot program to design a Phase 2/3 clinical trial with a reduced number of placebo patients, tweaking standards that have stymied other rare disease products......»»

Category: topSource: bizjournalsJan 15th, 2019

Cellular Biomedicine initiates recruitment for clinical trial in MM study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Novus Therapeutics doses first patient in phase 1 clinical trial of OP0201

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Arena says etrasimon showed long-term clinical remission in Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Pfizer initiates Phase 2b/3 clinical trial for PF-06651600

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 3rd, 2019

Seres Therapeutics initiates SER-287 Phase 2B ECO-RESET clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 3rd, 2019

Loxo Oncology initiates Phase 1/2 clinical trial of LOXO-305

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 21st, 2018